Advertisements


Sorrento Therapeutics expands clinical development of resiniferatoxin

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 15th, 2019

Sorrento Therapeutics to accelerate human IND filing of resiniferatoxin

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 10th, 2019

miRagen Therapeutics to Report First Quarter 2019 Financial Results and Host a Conference Call on May 8th

BOULDER, Colo., April 25, 2019 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of R.....»»

Category: earningsSource: benzingaApr 25th, 2019

Sangamo Therapeutics, Inc. (SGMO) Sangamo Clinical Development Update Conference Call (Transcript)

Sangamo Therapeutics, Inc. (SGMO) Sangamo Clinical Development Update Conference Call (Transcript).....»»

Category: topSource: seekingalphaApr 6th, 2019

The Wall Street Journal: Sorrento Therapeutics sues billionaire Soon-Shiong over development of cancer drug

Sorrento Therapeutics Inc. alleges billionaire Patrick Soon-Shiong and .....»»

Category: topSource: marketwatchApr 3rd, 2019

Y-mAbs Announces 2018 Financial Results and Corporate Development Highlights

NEW YORK, March 22, 2019 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the "Company" or "Y-mAbs") (NASDAQ:YMAB) a late-stage clinical bioph.....»»

Category: earningsSource: benzingaMar 22nd, 2019

Trillium Therapeutics Reports First Quarter 2018 Financial and Operating Results

Focusing TTI-621 clinical development on T.....»»

Category: earningsSource: benzingaMay 11th, 2018

Anchiano Therapeutics Reports Third Quarter 2018 Financial and Operational Results

CAMBRIDGE, Mass., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Anchiano Therapeutics (TASE: ANCN), a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer, today announced op.....»»

Category: earningsSource: benzingaNov 19th, 2018

Protagonist Therapeutics to begin clinical development of PN-10943

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 27th, 2018

ObsEva SA to Hold Fourth Quarter and Full Year 2018 Financial Results and Business Update Call on March 5, 2019

Geneva, Switzerland and Boston, MA –February 27, 2019 - ObsEva SA (NASDAQ:OBSV), a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman.....»»

Category: earningsSource: benzingaFeb 27th, 2019

Sarepta doubles down on gene therapies after early Limb-Girdle data

As some biotechs struggle to meet the expectations placed upon gene therapies, Sarepta Therapeutics is investing further in the field, announcing a deal to purchase its development partner for $165 million after positive early clinical trial data. .....»»

Category: topSource: bizjournalsFeb 27th, 2019

Analysts Laud Sarepta"s "Increasingly Active" Gene Therapy Clinical Development

Sarepta Therapeutics Inc (NASDAQ: SRPT) reported fourth-quarter results Wednesday alongside positive results for its muscular dystrophy gene therapy candidate. .....»»

Category: blogSource: benzingaFeb 28th, 2019

Wave Life Sciences to present overview of clinical development of suvodirsen

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 12th, 2019

Sorrento Therapeutics to explore potential IPO of Scilex Holding Company

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 12th, 2019

Sorrento Therapeutics Could IPO Its Scilex Unit

Sorrento Therapeutics Could IPO Its Scilex Unit.....»»

Category: blogSource: benzingaJun 12th, 2019

Hoth Therapeutics to begin production of BioLexa for clinical trials

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 10th, 2019

Enlivex Therapeutics provides clinical update on safety profile of Allocetra

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 6th, 2019

Sorrento Therapeutics" Scilex reports sales growth after post-merger integration

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 5th, 2019

LabCorp (LH) Closes Envigo Swap Deal, Expands in CRO Space

The conclusion of LabCorp's (LH) swap transaction will help enhance the company's Covance global nonclinical drug development capabilities with additional sites and resourc.....»»

Category: smallbizSource: nytJun 5th, 2019

Sorrento Therapeutics announce CBD JVs, commercial strategic partnerships

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 4th, 2019

Relmada Therapeutics presents development program of REL1017

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 31st, 2019